- Home
- SLGL vs RENB Comparison
SLGL vs RENB Comparison
Compare SLGL & RENB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLGL
- RENB
- Stock Information
- Founded
- SLGL 1997
- RENB 2011
- Country
- SLGL Israel
- RENB United States
- Employees
- SLGL N/A
- RENB N/A
- Industry
- SLGL Biotechnology: Pharmaceutical Preparations
- RENB Biotechnology: Pharmaceutical Preparations
- Sector
- SLGL Health Care
- RENB Health Care
- Exchange
- SLGL Nasdaq
- RENB Nasdaq
- Market Cap
- SLGL 69.1M
- RENB 57.7M
- IPO Year
- SLGL 2018
- RENB N/A
- Fundamental
- Price
- SLGL $23.98
- RENB $0.19
- Analyst Decision
- SLGL
- RENB
- Analyst Count
- SLGL 0
- RENB 0
- Target Price
- SLGL N/A
- RENB N/A
- AVG Volume (30 Days)
- SLGL 33.1K
- RENB 907.8K
- Earning Date
- SLGL 11-14-2025
- RENB 11-13-2025
- Dividend Yield
- SLGL N/A
- RENB N/A
- EPS Growth
- SLGL N/A
- RENB N/A
- EPS
- SLGL N/A
- RENB N/A
- Revenue
- SLGL $23,931,000.00
- RENB N/A
- Revenue This Year
- SLGL N/A
- RENB N/A
- Revenue Next Year
- SLGL $31.17
- RENB N/A
- P/E Ratio
- SLGL N/A
- RENB N/A
- Revenue Growth
- SLGL 264.86
- RENB N/A
- 52 Week Low
- SLGL $4.01
- RENB $0.18
- 52 Week High
- SLGL $30.00
- RENB $2.10
- Technical
- Relative Strength Index (RSI)
- SLGL 58.56
- RENB 36.34
- Support Level
- SLGL $23.13
- RENB $0.18
- Resistance Level
- SLGL $24.85
- RENB $0.22
- Average True Range (ATR)
- SLGL 2.36
- RENB 0.02
- MACD
- SLGL -0.43
- RENB -0.00
- Stochastic Oscillator
- SLGL 39.19
- RENB 10.48
About SLGL Sol-Gel Technologies Ltd.
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.
About RENB Renovaro Biosciences Inc.
Renovaro Inc is a biopharmaceutical company. It is engaged in developing new immunotherapies to combat cancer and developing a predicative artificial intelligence-based diagnostic methodology for the use of earlier cancer detection.